- Molecular NameIbudilast (MN-166)
- Synonym2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine; 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine; 3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine; AV-411; Eyevinal; I0157_SIGMA; Ibudilast (jan/inn); Ibudilast [inn:jan]; Ibudilastum; Ibudilastum [latin]; Ke tas; Ketas; Ketas (TN); Lopac-I-0157; MN-166; Pyrazolo(1,5-a)pyrdine, 3-isobutyryl-2-isopropyl-; Tocris-1694; UNII-M0TTH61XC5
- Weight230.311
- Drugbank_IDDB05266
- ACS_NO50847-11-5
- Show 2D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)3.07
- pkaN/A
- LogD (pH=7, predicted)3.07
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)-3.21
- LogSw (predicted, AB/LogsW2.0)0.19
- Sw (mg/ml) (predicted, ACD/Labs)0.14
- No.of HBond Donors0
- No.of HBond Acceptors3
- No.of Rotatable Bonds3
- TPSA34.89
- StatusFDA approved
- AdministrationN/A
- PharmacologyIbudilast (AV-411) is a non-selective phosphodiesterase inhibitor that is also known to suppress glial cell activation. It is tested for the treatment of asthma, neuropathic pain and opioid withdrawal syndromes.
- Absorption_valueN/A
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A